Basically, both companies have: • No revenues • Very promising pipelines • Novel technology platforms and not proven yet (as so many R working towards) • Leading vaccine candidates <<<<<<<<<
One huge difference is Moderna is more fully priced.
Within the coming months as we move closer, INO should have IO increase substantially and take the SP to $20-$40 and hold it there. And it will move sooo fast.
To me, this is a buy and hold and revisit in 4 months stock.
Daily fluctuations mean nothing at this point (unless wish to buy).
And if INO-4800 is safe, effective & works, $100+ SP with a tender $200+ (~$30B MC).